SCOPE FLUIDICS SA ZY-10

Research SCOPE FLUIDICS SA ZY-10 (S84) on Bullrun: market cap EUR 102.05M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerS84
ExchangeF
CountryPoland
SectorHealthcare
IndustryDiagnostics & Research
CurrencyEUR
Market capEUR 102.05M
Financial periodQ1 2026
RevenuePLN 27.00K
Net income-PLN 13.47M
Free cash flow-PLN 18.84M
Gross margin-2825.9%

Valuation Snapshot

latest market cap is EUR 102.05M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	PLN 100.00K	-PLN 46.36M	-PLN 59.50M	-3638.0%	n/a	PLN 93.15M	PLN 2.15M	PLN 162.43M
FY2023	PLN 516.00K	-PLN 18.79M	n/a	n/a	-6.89	PLN 66.29M	n/a	PLN 80.93M
FY2022	PLN 404.00K	PLN 318.49M	n/a	n/a	118.01	PLN 331.60M	n/a	PLN 332.97M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-24	EUR 102.05M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

Year	Dividends/share
FY2023	19.9 PLN

About SCOPE FLUIDICS SA ZY-10

Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. It offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is headquartered in Warsaw, Poland.

Related stock research

Poland stocks Poland Healthcare stocks A-Z stock index

Other Healthcare stocks

VOXEL SA ZY 1 (0NX) SELVITA S.A. SER.B ZY-80 (787) Diagnostyka S.A. (7JS) Biomaxima (BMX) ONCOARENDI THERAP ZY-01 (1B1) Mabion SA (272) BIOMED-LUBLIN WYT.SUR. (6NQ) NEUCA S.A. (7HD) CELON PHARMA S.A. ZY-10 (8RP) CANNABIS POLAND AB ZY-10 (8TE) COPLAND ROAD CAPITAL NEW (A2P) Airway Medix S.A. (D1C)

Frequently asked questions

What is SCOPE FLUIDICS SA ZY-10's market cap?

SCOPE FLUIDICS SA ZY-10's market capitalization is EUR 102.05M.